GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract HHSO100201100004CCHEMO-SERO-THERAPEUTIC RESEAECH INSTITUTE, THE

Overview

Award facts

Net obligations
$9.77M
$9,772,495of $33.93M potential value
Period of performance
Sep 25, 2018 to Sep 25, 2018
Ended
Modifications
10
Latest action Sep 25, 2018
Contract type
Definitive contract
PIID HHSO100201100004C

Description of requirement

KAKETSUKEN BASE YEAR FUNDING FOR THE ADVANCED DEVELOPMENT OF A LIVE ATTENUATED SMALLPOX VACCINE CAN1992002

Dates and value

Award date
Signed on Dec 17, 2010
Potential end of performance
Sep 24, 2018
Current value
$9,772,495Base and exercised options
Potential value (if all options are exercised)
$33,926,853

Obligations by fiscal year of action

  • FY2018: -$39,497 (de-obligation)
  • FY2011: $9,811,992

Total across 2 fiscal years: $9,772,495

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 25, 2018. View on USAspending · Recipient on SAM.gov

Recipient

LocationKUMAMOTO, JPN
UEIFEV7JWPM7J69
CAGE codeSHT60
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org

Business types and certifications

Foreign-ownedNonprofit organizationInternational organization

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Office Of Assistant Secretary For Preparedness And Response
  3. BARDA - ASPR / DAAPPO / BARDA DCMA
Funded from
075-0140Federal accounts (agency financial reports)

Place of performance

Place of performance
Japan

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
10

Contract details

Subcontracting plan
Plan not requiredB
Major program
Development of an alternative live attenuated vaccinia vaccine (LC16M8) for the prevention of smallp
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Dec 17, 2010Base obligation at award: $9,811,992
Latest action
Sep 25, 2018 — Other administrative actionModification 11; obligation change -$39,497; administrative: no change in scope or value
Latest substantive action
Sep 13, 2011 — Option exercisedModification 3
Actions by type
  • Base award1
  • Other administrative action9
  • Option exercised1
11 actions recorded, Dec 17, 2010 to Sep 25, 2018; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$39,497
Latest action: change in base and all options
-$39,497

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
JapanJPN
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7505
Contracting office code
75A501
Transactions recorded under this award key
11

Funding

Funding agency code
7500
Funding sub-tier code
7505
Funding office code
75A501
Treasury accounts
  • 075-2010/2013-0140-000
Object classes
  • 25.3: Other goods and services from Federal sources